Cargando…
Comment on “bevacizumab or laser for aggressive posterior retinopathy of prematurity”
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Wolters Kluwer - Medknow
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6557067/ https://www.ncbi.nlm.nih.gov/pubmed/31198675 http://dx.doi.org/10.4103/tjo.tjo_139_18 |
| _version_ | 1783425416746237952 |
|---|---|
| author | Samanta, Ramanuj |
| author_facet | Samanta, Ramanuj |
| author_sort | Samanta, Ramanuj |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-6557067 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2019 |
| publisher | Wolters Kluwer - Medknow |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-65570672019-06-13 Comment on “bevacizumab or laser for aggressive posterior retinopathy of prematurity” Samanta, Ramanuj Taiwan J Ophthalmol Letter to the Editor Wolters Kluwer - Medknow 2019 /pmc/articles/PMC6557067/ /pubmed/31198675 http://dx.doi.org/10.4103/tjo.tjo_139_18 Text en Copyright: © 2019 Taiwan J Ophthalmol http://creativecommons.org/licenses/by-nc-sa/4.0 This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms. |
| spellingShingle | Letter to the Editor Samanta, Ramanuj Comment on “bevacizumab or laser for aggressive posterior retinopathy of prematurity” |
| title | Comment on “bevacizumab or laser for aggressive posterior retinopathy of prematurity” |
| title_full | Comment on “bevacizumab or laser for aggressive posterior retinopathy of prematurity” |
| title_fullStr | Comment on “bevacizumab or laser for aggressive posterior retinopathy of prematurity” |
| title_full_unstemmed | Comment on “bevacizumab or laser for aggressive posterior retinopathy of prematurity” |
| title_short | Comment on “bevacizumab or laser for aggressive posterior retinopathy of prematurity” |
| title_sort | comment on “bevacizumab or laser for aggressive posterior retinopathy of prematurity” |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6557067/ https://www.ncbi.nlm.nih.gov/pubmed/31198675 http://dx.doi.org/10.4103/tjo.tjo_139_18 |
| work_keys_str_mv | AT samantaramanuj commentonbevacizumaborlaserforaggressiveposteriorretinopathyofprematurity |